NSE - Free Realtime Quote INR
Pfizer Limited (PFIZER.NS)
4,449.00
+35.80
+(0.81%)
As of 2:26:30 PM GMT+5:30. Market Open.
Research Analysis
Earnings Estimate
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 2 | 2 |
Avg. Estimate | 36.3 | 0 | 131.9 | 149.6 |
Low Estimate | 36.3 | 0 | 128.2 | 145 |
High Estimate | 36.3 | 0 | 135.6 | 154.2 |
Year Ago EPS | -- | -- | 119.22 | 131.9 |
Revenue Estimate
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | -- | 2 | 2 |
Avg. Estimate | 5.99B | -- | 22.56B | 24.6B |
Low Estimate | 5.79B | -- | 22.54B | 24.49B |
High Estimate | 6.19B | -- | 22.58B | 24.72B |
Year Ago Sales | 5.47B | -- | 21.93B | 22.56B |
Sales Growth (year/est) | 9.65% | -- | 2.88% | 9.05% |
Earnings History
Currency in INR | 6/30/2024 | 9/30/2024 |
---|---|---|
EPS Est. | 32.7 | 37 |
EPS Actual | 32.94 | 34.61 |
Difference | 0.24 | -2.39 |
Surprise % | 0.73% | -6.46% |
EPS Trend
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 36.3 | 0 | 131.9 | 149.6 |
7 Days Ago | 0 | 0 | 131.9 | 149.6 |
30 Days Ago | 0 | 0 | 131.9 | 149.6 |
60 Days Ago | 0 | 0 | 131.9 | 149.6 |
90 Days Ago | 0 | 0 | 139.6 | 162.25 |
EPS Revisions
Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | 2 | 2 |
Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PFIZER.NS | -- | -- | 10.64% | 13.42% |
S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Related Tickers
GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
2,824.90
-0.13%
SANOFI.NS Sanofi India Limited
6,293.00
+0.11%
BRM.BE Bristol-Myers Squibb Co
41.42
+1.82%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,827.45
-0.01%
PFE.DE Pfizer Inc.
20.17
-0.49%
GSK GSK plc
37.64
+1.34%
PFE Pfizer Inc.
22.83
+1.02%
AMGN Amgen Inc.
272.41
+1.15%
NVO Novo Nordisk A/S
64.37
-2.69%
BMY Bristol-Myers Squibb Company
46.75
+2.05%